VIRPAX PHARMACEUTICALS INC
CUSIP 928251107
Virpax Pharmaceuticals Inc has 16 institutional holders in Filings Flow’s 13F database, together reporting 1.37M shares worth $740,309 as of Q4 2022. The largest reported holders are Sabby Management, LLC, Pnc Financial Services Group, Inc., and Geode Capital Management, LLC.
Institutional Holders
16
Q4 2022
Reported Value
$740,309
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| SHEETS SMITH WEALTH MANAGEMENT$1.0B AUM | 0.00% | $16,005 | 50.0K | Q4 2023OLDER |
| Signature Resources Capital Management, LLC$211M AUM | 0.00% | $160 | 500 | Q4 2023OLDER |
| TWO SIGMA SECURITIES, LLC$861M AUM | 0.00% | $3,744 | 11.7K | Q4 2023OLDER |
| PNC FINANCIAL SERVICES GROUP, INC.$173.2B AUM | 0.00% | $32,280 | 100.9K | Q4 2023OLDER |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $2,022 | 6.3K | Q4 2023OLDER |
| RENAISSANCE TECHNOLOGIES LLC$63.9B AUM | 0.00% | $10 | 30.5K | Q4 2023OLDER |
| GEODE CAPITAL MANAGEMENT, LLC$1.61T AUM | 0.00% | $20,162 | 63.9K | Q4 2023OLDER |
| OSAIC HOLDINGS, INC.$68.3B AUM | 0.00% | $768 | 2.4K | Q4 2023OLDER |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM | 0.00% | $5,590 | 17.7K | Q4 2023OLDER |
| NORTHERN TRUST CORP$756.6B AUM | 0.00% | $4,872 | 15.2K | Q4 2023OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $2,117 | 6.6K | Q4 2023OLDER |
| Parallel Advisors, LLC$5.6B AUM | 0.00% | $1 | 1 | Q2 2024 |
| BlackRock Finance, Inc.$4.42T AUM | 0.00% | $149 | 464 | Q4 2023OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.